EU HTA Regulation and Joint Clinical Assessment-Threat or Opportunity? [0.03%]
欧盟HTA条例及联合临床评估：威胁还是机遇？
Volker Schuster
Volker Schuster
The vision of a unified European HTA is by no means a new endeavor. At its core are the publicly declared ambitions to harmonize assessments of clinical data within the EU and avoid the duplication of efforts. Not surprisingly, these ambiti...
Cost-Effectiveness Analysis of Innovative Therapies for Patients with Non-Alcoholic Fatty Liver Disease [0.03%]
非酒精性脂肪肝病创新疗法的成本效果分析
Michal Pochopien,Jakub Wladyslaw Dziedzic,Samuel Aballea et al.
Michal Pochopien et al.
Objective: Currently there are no disease-specific approved therapies for non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH); however, several treatments are under development. This study aimed to e...
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review [0.03%]
间接治疗比较的方法学：一项系统文献回顾的结果分析
Bérengère Macabeo,Arthur Quenéchdu,Samuel Aballéa et al.
Bérengère Macabeo et al.
Introduction: Health technology assessment (HTA) agencies express a clear preference for randomized controlled trials when assessing the comparative efficacy of two or more treatments. However, an indirect treatment compa...
Comparative Clinical Effectiveness and Cost-Effectiveness of the Cochlear Osia System and Baha Attract System in Patients with Conductive or Mixed Hearing Loss or Single-Sided Deafness [0.03%]
柳叶刀耳部疾病：关于柳叶刀听力植入系统和骨桥吸引系统的比较临床疗效和成本效益的一项多中心随机对照试验
Matthias Brunner,Manjula Schou,Robert J Briggs et al.
Matthias Brunner et al.
The aim of this study was to evaluate the comparative clinical effectiveness and cost-utility of the active transcutaneous Osia® System versus the passive transcutaneous Baha® Attract System for patients with conductive or mixed hearing l...
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators [0.03%]
呼吁行动确保欧盟HTA条例实施过程中有关利益相关者和合作者适当参与的包容性民间社会对话
Thomas Desmet,Elaine Julian,Walter Van Dyck et al.
Thomas Desmet et al.
Objectives: Stakeholder involvement has long been considered a success factor for a joint European health technology assessment (HTA) process, and its relevance is now anchored in the EU HTA Regulation's (EU HTAR) legisla...
Welcome to the Journal of Market Access and Health Policy under MDPI Wings [0.03%]
欢迎来到MDPI翅膀下的市场准入与卫生政策期刊
Mondher Toumi
Mondher Toumi
Inappropriate dosing of direct oral anticoagulants: findings from a clinical vignette study and physician survey [0.03%]
直接口服抗凝药不合理用药的现状及原因——临床案例研究和医生调查的结果
Ahmet Fuat,Emmanuel Ako,David Hargroves et al.
Ahmet Fuat et al.
Objective: Direct oral anticoagulants (DOACs) are first-line therapy for stroke prevention for 1.4 million atrial fibrillation (AF) patients in the UK. However, the rates of DOAC dosing below evidence-based recommendation...
Baudouin Standaert,Olivier Ethgen
Baudouin Standaert
At least since the Age of Enlightenment, good health has been a tenet for society. Healthy societies could learn better, work harder, improve their wealth, and live longer. Today societies focus on life expectancy, as we value long and heal...
Ivabradine in patients with heart failure: a systematic literature review [0.03%]
心力衰竭患者中的伊伐布雷定：系统文献回顾
Zeba M Khan,Jean Baptiste Briere,Elzbieta Olewinska et al.
Zeba M Khan et al.
Background: Heart failure is a chronic disease linked with significant morbidity and mortality, and uncontrolled resting heart rate is a risk factor for adverse outcomes. This systematic literature review aimed to assess the efficacy, safet...